{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2024-P-2778\" sorted by posted_date descending", "rows": [["FDA-2024-P-2778-0013", "FDA", "FDA-2024-P-2778", "Final Response Letter from FDA CDER to Pharmobedient Consulting, LLC", "Other", "Denial of Petition", "2024-12-26T05:00:00Z", 2024, 12, "2024-12-26T05:00:00Z", null, "2024-12-26T17:30:38Z", null, 0, 0, "090000648688c866"], ["FDA-2024-P-2778-0012", "FDA", "FDA-2024-P-2778", "Completeness Assessment Correspondence", "Other", "Assessment Document or Analysis", "2024-07-10T04:00:00Z", 2024, 7, "2024-07-10T04:00:00Z", null, "2024-07-10T18:54:18Z", null, 0, 0, "09000064865e6919"], ["FDA-2024-P-2778-0010", "FDA", "FDA-2024-P-2778", "Attachment 4 - Draft Guidance on Chlorzoxazone", "Supporting & Related Material", "Background Material", "2024-07-01T04:00:00Z", 2024, 7, null, null, "2024-07-01T17:47:08Z", null, 0, 0, "09000064865d5493"], ["FDA-2024-P-2778-0008", "FDA", "FDA-2024-P-2778", "Attachment 1 - Orange Book for PARAFON FORTE DSC", "Supporting & Related Material", "Background Material", "2024-07-01T04:00:00Z", 2024, 7, null, null, "2024-07-01T17:46:59Z", null, 0, 0, "09000064865d5491"], ["FDA-2024-P-2778-0009", "FDA", "FDA-2024-P-2778", "Attachment 2 - RS under ANDA 089859 Revised 7 2019", "Supporting & Related Material", "Background Material", "2024-07-01T04:00:00Z", 2024, 7, null, null, "2024-07-01T17:47:03Z", null, 0, 0, "09000064865d5492"], ["FDA-2024-P-2778-0011", "FDA", "FDA-2024-P-2778", "Attachment 5 - Chlorzoxazone Orally Disintegrating Tablets", "Supporting & Related Material", "Background Material", "2024-07-01T04:00:00Z", 2024, 7, null, null, "2024-07-01T17:47:14Z", null, 0, 0, "09000064865d5494"], ["FDA-2024-P-2778-0007", "FDA", "FDA-2024-P-2778", "Suitability Petition Amendment from Pharmobedient Consulting LLC", "Other", "Amendment", "2024-07-01T04:00:00Z", 2024, 7, "2024-07-01T04:00:00Z", null, "2024-07-01T17:46:52Z", null, 0, 0, "09000064865d5630"], ["FDA-2024-P-2778-0002", "FDA", "FDA-2024-P-2778", "Acknowledgment Letter from FDA DMS to Pharmobedient Consulting, LLC", "Other", "Acknowledgement Letter/Receipt", "2024-06-11T04:00:00Z", 2024, 6, "2024-06-11T04:00:00Z", null, "2024-06-11T14:51:05Z", null, 0, 0, "09000064865a7a6e"], ["FDA-2024-P-2778-0006", "FDA", "FDA-2024-P-2778", "Attachment 4 - FDA BE guidance PSG_011529", "Supporting & Related Material", "Background Material", "2024-06-11T04:00:00Z", 2024, 6, null, null, "2024-06-11T14:51:53Z", null, 0, 0, "09000064865a7dd5"], ["FDA-2024-P-2778-0005", "FDA", "FDA-2024-P-2778", "Attachment 3 - Chloroxazone PI-ODT Revision-06.07.24", "Supporting & Related Material", "Background Material", "2024-06-11T04:00:00Z", 2024, 6, null, null, "2024-06-11T14:51:38Z", null, 0, 0, "09000064865a7dd3"], ["FDA-2024-P-2778-0004", "FDA", "FDA-2024-P-2778", "Attachment 2 - RS Labeling", "Supporting & Related Material", "Background Material", "2024-06-11T04:00:00Z", 2024, 6, null, null, "2024-06-11T14:51:29Z", null, 0, 0, "09000064865a7dd2"], ["FDA-2024-P-2778-0001", "FDA", "FDA-2024-P-2778", "Suitability Petition from Pharmobedient Consulting, LLC", "Other", "Petition(s)", "2024-06-11T04:00:00Z", 2024, 6, "2024-06-11T04:00:00Z", null, "2024-12-26T15:42:08Z", null, 0, 0, "09000064865a7a6d"], ["FDA-2024-P-2778-0003", "FDA", "FDA-2024-P-2778", "Attachment 1 -Orange Book - Paraforn Forte DSC", "Supporting & Related Material", "Background Material", "2024-06-11T04:00:00Z", 2024, 6, null, null, "2024-06-11T14:51:19Z", null, 0, 0, "09000064865a7dcd"]], "truncated": false, "filtered_table_rows_count": 13, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2024-P-2778"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2024-P-2778", "results": [{"value": "FDA", "label": "FDA", "count": 13, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2024-P-2778&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2024-P-2778", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 8, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2024-P-2778&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 5, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2024-P-2778&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2024-P-2778", "results": [{"value": 2024, "label": 2024, "count": 13, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2024-P-2778&posted_year=2024", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2024-P-2778&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2024-P-2778&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2024-P-2778&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2024-P-2778&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2024-P-2778&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2024-P-2778&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2024-P-2778&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 2005.8514398988336, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}